ArticleThe Lancet. Oncology2018
The first prospective trial for von Hippel-Lindau disease: pazopanib.
Rachel H Giles et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleThe Lancet. Oncology2018
Rachel H Giles et al.PubMed ↗Publisher ↗
No numbers read from the abstract.